Skip to content

Avobenzone

Anthelios Sx, Capital Soleil (avobenzone) is a small molecule pharmaceutical. Avobenzone was first approved as Anthelios Sx on 2006-07-21. It is used to treat photosensitivity disorders in the USA.
Trade Name Anthelios Sx, Capital Soleil
Common Name Avobenzone
Indication photosensitivity disorders
Drug Class
Avobenzone
Get full access now